AVISTA is pleased to be invited by the Hong Kong Institute of Certified Public Accountants (HKICPA) to be the gold sponsor of the HKICPA Business Case Competition 2021. Hosted by the HKICPA for 19 consecutive years, this year’s competition put a spotlight on the fashion industry and has received very positive response from around 2,500 sub-degree and undergraduate students, with 520 business proposals submitted from approximately 70 institutions across Mainland China, Hong Kong and Macau. Our sincerest congratulations to the winners! AVISTA is glad to have witnessed the outstanding efforts exerted by the contestant teams in contributing innovative ideas and feasible solutions to create value and unlock growth for the fashion industry. <img src="../../../../../uploads/HKICPA_BCC_2021_0802_84f482a5b1.JPG" alt="" width="533" height="355" /> <img src="../../../../../uploads/HKICPA_BCC_2021_0813_2681022628.JPG" alt="" width="533" height="355" /> <img src="../../../../../uploads/HKICPA_BCC_2021_0800_a3b6eb1cd0.JPG" alt="" width="533" height="355" /> <img src="../../../../../uploads/HKICPA_BCC_2021_0793_0c0291afa3.JPG" alt="" width="533" height="355" /> <img src="../../../../../uploads/poster_resized_142d79425e.png" alt="" width="533" height="802" />

banner1

As the Gold Sponsor of the HKICPA Business Case Competition 2021

Congratulations to Xunfei Healthcare Technology Co., Ltd. (2506.HK) on its successful Listing on the Mainboard of HKSE on 30 December 2024
 
Xunfei Healthcare Technology Co., Ltd. (“Xunfei Healthcare”) is an AI-empowered healthcare solution provider committed to empowering the healthcare industry with AI technologies and realizing large-scale commercialization of healthcare AI solutions in China. The Company’s products and solutions support a range of healthcare services, ranging from health risk warnings, early screening, auxiliary diagnosis and treatment as well as treatment effect evaluation to post-discharge management and chronic disease management.
 
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services on expected credit loss, goodwill impairment and development expenses impairment.
 
Congratulations again to Xunfei Healthcare Technology Co., Ltd. (2506.HK) on its successful listing. The issue price is HKD 82.80 per share, and the amount of funds raised is HKD 583 million.
 
<img src="../../../../../uploads/Slide1_7bf0ba6d9d.png" width="500" />

57205355_l.png

Congratulations to Xunfei Healthcare Technology Co., Ltd. (2506.HK) on its Successful Listing

Congratulations to Xiaocaiyuan International Holding Ltd. (0999.HK) on its successful Listing on the Mainboard of HKSE on 20 December 2024
 
Xiaocaiyuan International Holding Ltd. (“Xiaocaiyuan”) is one of the renowned self-operated chain restaurants in China’s mass Chinese cuisine market. According to Frost &amp; Sullivan, the mass Chinese cuisine market is a sub-segment of Chinese cuisine market with average spending per consumer below RMB100. Capitalizing on our deep comprehension of China’s evolving catering industry, the anticipated modernization and industrialization in the industry, and the inherent consumer demand, Xiaocaiyuan strategically ventured into the growing mass Chinese cuisine sector. Since our establishment in 2013, Xiaocaiyuan has been striving to offer consumers home-style flavor dishes and attentive services at affordable prices. As of the Latest Practicable Date, Xiaocaiyuan has 663 self-operated restaurants under operation, with a coverage of 146 cities or counties across 14 provinces in China.
 
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services on restricted stock unit, preferred stocks and convertible bonds.
 
Congratulations again to Xiaocaiyuan International Holding Ltd. (0999.HK) on its successful listing. The issue price is HKD 8.50 per share, and the amount of funds raised is HKD 860 million.
 
<img src="../../../../../uploads/Slide1_0d0eb69d3f.png" width="500" />

37819644_l.png

Congratulations to Xiaocaiyuan International Holding Ltd. (0999.HK) on its Successful Listing

Congratulations to Dmall Inc. (2586.HK) on its successful Listing on the Mainboard of HKSE on 6 December 2024
 
Dmall Inc. (“Dmall”) is one of the largest retail digitalization solution service providers in China, offering retail digitalization solutions to leading retailers in the local retail industry. The company has served most of the leading retail enterprises in China and has successfully expanded its business to other countries and regions outside of China. As of June 30, 2024, including Hong Kong and Macao in China, as well as Cambodia, the Philippines, Malaysia, Indonesia, Singapore, Poland, and Brunei, the company's overseas revenue has exceeded the billion-yuan mark.
 
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services in relation to purchase price allocation analysis, goodwill impairment test, financial assets and property.
 
Congratulations again to Dmall Inc. (2586.HK) on its successful listing. The issue price is HKD 30.21 per share, and the amount of funds raised is HKD 778.6million.
 
<img src="../../../../../uploads/Slide1_2c00df3a5f.png" width="500" />